Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Dec;44(12):1278-1286.
doi: 10.1177/10711007231198822. Epub 2023 Oct 11.

Establishment of a Neurodegenerative Charcot Mouse Model

Affiliations
Comment

Establishment of a Neurodegenerative Charcot Mouse Model

Zachary A Koroneos et al. Foot Ankle Int. 2023 Dec.

Abstract

Background: This study aimed to mimic the changes from Charcot neuropathic arthropathy in humans by examining the effects of exposing diet-induced obese (DIO) mice to neurotrauma through a regimented running protocol.

Methods: Forty-eight male wild-type C57BL/6J mice were obtained at age 6 weeks and separated into 2 groups for diet assignment. After a 1-week acclimation period, half of the mice consumed a high-fat diet (60% fat by kcal) ad libitum to facilitate neuropathic diet-induced obesity whereas the other half were control mice and consumed an age-matched standard low-fat control diet (10% fat by kcal). At age 12 weeks, half of the animals from each group were subjected to a high-intensity inclined treadmill running protocol, which has been previously demonstrated to induce neurotrauma. Sensory testing and radiographic analyses were periodically performed. Histopathologic analyses were performed post killing.

Results: DIO mice had significantly higher bodyweights, higher body fat percentages, and lower bone mineral density than wildtype control mice that were fed a normal diet throughout the experiment (P < .001 for each). DIO mice displayed significantly reduced sensory function in week 1 (P = .005) and this worsened over time, requiring 20.6% more force for paw withdrawal by week 10 (P < .001). DIO mice that ran demonstrated greater midfoot subluxation and tarsal instability over all time points compared with normal-diet mice that ran (P < .001). Histopathologic analyses revealed that DIO mice that ran demonstrated significant changes compared with controls that ran (P < .001 for each parameter).

Conclusion: Changes akin to the earliest changes observed in or before joint destruction identified in diabetic Charcot neuropathic arthropathy in humans were observed.

Clinical relevance: There is currently no standard of treatment for patients with Charcot neuropathic arthropathy. This study establishes a protocol for an animal model that can be used to study and compare interventions to treat this disease.

Keywords: Charcot neuroarthropathy; microtrauma; neuropathic mouse; obese animal model; treadmill running.

PubMed Disclaimer

Conflict of interest statement

Declaration of Conflicting InterestsThe author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article. ICMJE forms for all authors are available online.

Figures

Figure 1.
Figure 1.
Comparison of (A) average weight, (B) bodyfat percentage, and (C) bone mineral density throughout the experiment (n = 12 per group). Error bars indicate standard error of the mean. *, **, and *** indicate significant differences at P < .05, P < .01, and P < .001, respectively.
Figure 2.
Figure 2.
Comparison of the force required to elicit a positive response in mouse hind paw using von Frey filament over the 10-week time period (n = 12 per group). Error bars indicate standard error of the mean. ** and *** indicate significant differences at P < .01 and P < .001, respectively.
Figure 3.
Figure 3.
Comparisons of (A) subluxation percentage of the tarsal over the metatarsal bones (B) Meary angle, and (C) calcaneus–fifth metatarsal angle between each group over the duration of the study (n = 12 per group). Error bars indicate standard error of the mean. *, **, and *** indicate significant differences at P < .05, P < .01, and P < .001, respectively.
Figure 4.
Figure 4.
Graphic representation of histopathologic changes of Charcot neuropathic arthropathy model (n = 12 per group). This includes assessments of nerve intraneural myxoid (edema) change and fibrosis (column 1), small vessel arteriolosclerosis (column 2), articular peculiar perichondral ossification (column 3), subchondral osteosclerosis (microfracture endochondral ossification) (column 4), increased distance from the articular surface to closest marrow space due to osteosclerosis (column 6), and cortex endochondral ossification remodeling (column 5). The level of degenerative changes on this plot correlates to the scores for the respective grading scale for each measurement.
Figure 5.
Figure 5.
Representative radiographic images in the sagittal plane of (A) diet-induced obese runner (DIO+R) with Meary angle and calcaneal–fifth metatarsal angle and (B) midfoot subluxation. As a comparison, wildtype control nonrunner (WTC) mouse (C) Meary angle and calcaneal–fifth metatarsal angles, and (D) measured midfoot subluxation.

Comment on

References

    1. Armstrong DG, Peters EJG. Charcot’s arthropathy of the foot. J Am Podiatr Med Assoc. 2002;92(7):390-394. doi:10.7547/87507315-92-7-390 - DOI - PubMed
    1. Belmont PJ, Davey S, Orr JD, Ochoa LM, Bader JO, Schoenfeld AJ. Risk factors for 30-day postoperative complications and mortality after below-knee amputation: a study of 2,911 patients from the national surgical quality improvement program. J Am Coll Surg. 2011;213(3):370-378. doi:10.1016/J.JAMCOLLSURG.2011.05.019 - DOI - PubMed
    1. Biessels GJ, Bril V, Calcutt NA, et al.. Phenotyping animal models of diabetic neuropathy: a consensus statement of the diabetic neuropathy study group of the EASD (Neurodiab). J Peripher Nerv Syst. 2014;19(2):77-87. doi:10.1111/JNS5.12072 - DOI - PMC - PubMed
    1. Bruna J, Alberti P, Calls-Cobos A, Caillaud M, Damaj MI, Navarro X. Methods for in vivo studies in rodents of chemotherapy induced peripheral neuropathy. Exp Neurol. 2020;325:113154. doi:10.1016/j.expneurol.2019.113154 - DOI - PMC - PubMed
    1. Caffarelli C, Alessi C, Nuti R, Gonnelli S. Divergent effects of obesity on fragility fractures. Clin Interv Aging. 2014;9:1629-1636. doi:10.2147/CIA.S64625 - DOI - PMC - PubMed